Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Usami

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Die Pharmazie|June 15, 2024
Pharmacist-initiated interventions to test quantitative bone mineral density and prescribe osteoporosis medications to prevent steroid-induced osteoporosisT Hirose, K Mori, M Kimura, et al.
Die Pharmazie|May 24, 2016
Safety of an oral anticancer agent (trifluridine/tipiracil combination tablet) in patients with advanced and recurrent colorectal cancerM Kimura, M Go, M Iwai, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 1, 1983
[Studies on the action of elastase; effect of elastase on the metabolism of lipids and connective tissues in experimental atherosclerosis]Y Seyama, E Usami, S Yamashita, et al.
Molecular and Clinical Oncology|August 14, 2018
Cost-effectiveness and safety of the molecular targeted drugs afatinib, gefitinib and erlotinib as first-line treatments for patients with advanced EGFR mutation-positive non-small-cell lung cancerM Kimura, F Yasue, E Usami, et al.
Die Pharmazie|May 9, 2021
Association between immune-related dermatologic adverse events and efficacy of pembrolizumab in non-small cell lung cancer patientsT Fukuoka, Y Yamamoto, J Utsunomiya, et al.
Biological & Pharmaceutical Bulletin|October 1, 1995
Effect of theophylline on the production of interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-8 by human peripheral blood mononuclear cellsT Yoshimura, E Usami, C Kurita, et al.
Die Pharmazie|March 17, 2018
Risk factors contributing to the development of neutropenia in patients receiving oral trifluridine-tipiracil (TAS-102) chemotherapy for advanced/recurrent colorectal cancerF Yasue, M Kimura, E Usami, et al.
Chemotherapy|November 1, 1996
Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cellsT Yoshimura, C Kurita, E Usami, et al.
Die Pharmazie|June 3, 2022
Expression of Vincristin-induced Peripheral Neuropathy Related to Different Administration MethodsT Fukuoka, Y Yamamoto, E Usami, et al.
Die Pharmazie|July 27, 2016
Risk factors for neutropenia with lenalidomide plus dexamethasone therapy for multiple myelomaY Mitani, E Usami, M Kimura, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Die Pharmazie|June 15, 2024
Pharmacist-initiated interventions to test quantitative bone mineral density and prescribe osteoporosis medications to prevent steroid-induced osteoporosisT Hirose, K Mori, M Kimura, et al.
Die Pharmazie|May 24, 2016
Safety of an oral anticancer agent (trifluridine/tipiracil combination tablet) in patients with advanced and recurrent colorectal cancerM Kimura, M Go, M Iwai, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 1, 1983
[Studies on the action of elastase; effect of elastase on the metabolism of lipids and connective tissues in experimental atherosclerosis]Y Seyama, E Usami, S Yamashita, et al.
Molecular and Clinical Oncology|August 14, 2018
Cost-effectiveness and safety of the molecular targeted drugs afatinib, gefitinib and erlotinib as first-line treatments for patients with advanced EGFR mutation-positive non-small-cell lung cancerM Kimura, F Yasue, E Usami, et al.
Die Pharmazie|May 9, 2021
Association between immune-related dermatologic adverse events and efficacy of pembrolizumab in non-small cell lung cancer patientsT Fukuoka, Y Yamamoto, J Utsunomiya, et al.
Biological & Pharmaceutical Bulletin|October 1, 1995
Effect of theophylline on the production of interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-8 by human peripheral blood mononuclear cellsT Yoshimura, E Usami, C Kurita, et al.
Die Pharmazie|March 17, 2018
Risk factors contributing to the development of neutropenia in patients receiving oral trifluridine-tipiracil (TAS-102) chemotherapy for advanced/recurrent colorectal cancerF Yasue, M Kimura, E Usami, et al.
Chemotherapy|November 1, 1996
Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cellsT Yoshimura, C Kurita, E Usami, et al.
Die Pharmazie|June 3, 2022
Expression of Vincristin-induced Peripheral Neuropathy Related to Different Administration MethodsT Fukuoka, Y Yamamoto, E Usami, et al.
Die Pharmazie|July 27, 2016
Risk factors for neutropenia with lenalidomide plus dexamethasone therapy for multiple myelomaY Mitani, E Usami, M Kimura, et al.
Pageof 4